Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elrom Ventures appears to be an active venture investment firm rather than an operating biotech, pharma, or healthcare product company. Publicly available information indicates that it was founded in 2007 and is associated with investments in medical, biotechnology, and green technology companies, with Dr. Rom Eliaz identified in multiple sources as founder and managing director. Available records also show a legal entity named ELROM VENTURES CORPORATION in California and references to operations tied to Israel and the United States. There is no clear evidence that Elrom Ventures itself develops therapeutic products, runs a clinical pipeline, or commercializes healthcare products directly. As a result, the entity is best characterized as a life-science-oriented investment vehicle with healthcare exposure rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elrom Ventures.